Dysregulation of proinflammatory versus anti-inflammatory human TH17 cell functionalities in the autoinflammatory Schnitzler syndrome

Journal of Allergy and Clinical Immunology

Volumn 138, Issue 4, 2016, Pages 1161-1169.e6

  Noster, Rebecca ^a   de Koning, Heleen D ^c,d   Maier, Elisabeth ^b   Prelog, Martina ^e   Lainka, Elke ^f   Zielinski, Christina E ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d N4i Centre for Immunodeficiency and Autoinflammation   (Netherlands)

^e UNIVERSITY OF WÜRZBURG   (Germany)

^f UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Autoinflammation; IL 10; IL 1 ; Schnitzler syndrome; TH17 cells

Indexed keywords

CANAKINUMAB; CD14 ANTIGEN; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; GEVOKIZUMAB; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 22; INTERLEUKIN 7 RECEPTOR; RECOMBINANT INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; CYTOKINE;

ANTIGEN PRESENTING CELL; ARTHRALGIA; ARTICLE; AUTOINFLAMMATORY DISEASE; CELL ISOLATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEEDER CELL; HELPER CELL; HUMAN; HUMAN CELL; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT FEVER; REGULATORY T LYMPHOCYTE; SCHNITZLER SYNDROME; SUPPRESSOR CELL; TH17 CELL; CELL CULTURE; DRUG DELIVERY SYSTEM; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOPHYSIOLOGY;

CELLS, CULTURED; CYTOKINES; DRUG DELIVERY SYSTEMS; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; SCHNITZLER SYNDROME; TH17 CELLS;

EID: 84962119067     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.12.1338     Document Type: Article

References (26)

1. 1 Sallusto, F., Zielinski, C.E., Lanzavecchia, A., Human Th17 subsets. Eur J Immunol 42 (2012), 2215–2220.
2. 2 Schmidt-Weber, C.B., Akdis, M., Akdis, C.A., TH17 cells in the big picture of immunology. J Allergy Clin Immunol 120 (2007), 247–254.
3. 3 McGeachy, M.J., Bak-Jensen, K.S., Chen, Y., Tato, C.M., Blumenschein, W., McClanahan, T., et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 8 (2007), 1390–1397.
4. 4 Zielinski, C.E., Mele, F., Aschenbrenner, D., Jarrossay, D., Ronchi, F., Gattorno, M., et al. Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature 484 (2012), 514–518.
5. 5 Martinon, F., Tschopp, J., Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117 (2004), 561–574.
6. 6 Lipsker, D., The Schnitzler syndrome. Orphanet J Rare Dis, 5, 2010, 38.
7. 7 de Koning, H.D., Bodar, E.J., van der Meer, J.W., Simon, A., Schnitzler Syndrome Study Group. Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum 37 (2007), 137–148.
8. 8 de Koning, H.D., van Gijn, M.E., Stoffels, M., Jongekrijg, J., Zeeuwen, P.L., Elferink, M.G., et al. Myeloid lineage-restricted somatic mosaicism of NLRP3 mutations in patients with variant Schnitzler syndrome. J Allergy Clin Immunol 135 (2015), 561–564.
9. 9 Ryan, J.G., de Koning, H.D., Beck, L.A., Booty, M.G., Kastner, D.L., Simon, A., IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission. J Allergy Clin Immunol 121 (2008), 260–262.
10. 10 Krause, K., Tsianakas, A., Wagner, N., Fischer, J., Weller, K., Metz, M., et al. Effectiveness of canakinumab treatment in Schnitzler's syndrome: a multi-center randomized placebo-controlled study. Pediatr Rheumatol, 13(suppl 1), 2015, O66.
11. 11 Acosta-Rodriguez, E.V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8 (2007), 639–646.
12. 12 Codarri, L., Gyulveszi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., et al. RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat Immunol 12 (2011), 560–567.
13. 13 El-Behi, M., Ciric, B., Dai, H., Yan, Y., Cullimore, M., Safavi, F., et al. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat Immunol 12 (2011), 568–575.
14. 14 Noster, R., Riedel, R., Mashreghi, M.F., Radbruch, H., Harms, L., Haftmann, C., et al. IL-17 and GM-CSF expression are antagonistically regulated by human T helper cells. Sci Transl Med, 6, 2014, 241ra80.
15. 15 Josefowicz, S.Z., Lu, L.F., Rudensky, A.Y., Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 30 (2012), 531–564.
16. 16 Shevach, E.M., Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30 (2009), 636–645.
17. 17 Stoffels, M., Zaal, R., Kok, N., van der Meer, J.W., Dinarello, C.A., Simon, A., ATP-induced IL-1beta specific secretion: true under stringent conditions. Front Immunol, 6, 2015, 54.
18. 18 Goldbach-Mansky, R., Kastner, D.L., Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses. J Allergy Clin Immunol 124 (2009), 1141–1151.
19. 19 Launay, D., Dutoit-Lefevre, V., Faure, E., Robineau, O., Hauspie, C., Sobanski, V., et al. Effect of in vitro and in vivo anakinra on cytokines production in Schnitzler syndrome. PLoS One, 8, 2013, e59327.
20. 20 Jesus, A.A., Goldbach-Mansky, R., IL-1 blockade in autoinflammatory syndromes. Annu Rev Med 65 (2014), 223–244.
21. 21 Yao, Y., Vent-Schmidt, J., McGeough, M.D., Wong, M., Hoffman, H.M., Steiner, T.S., et al. Tr1 cells, but not Foxp3+ regulatory T cells, suppress NLRP3 inflammasome activation via an IL-10-dependent mechanism. J Immunol 195 (2015), 488–497.
22. 22 Akdis, C.A., Akdis, M., Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol 123 (2009), 735–748.
23. 23 Facciotti, F., Gagliani, N., Haringer, B., Alfen, J.S., Penatti, A., Maglie, S., et al. IL-10-producing forkhead box protein 3-negative regulatory T cells inhibit B-cell responses and are involved in systemic lupus erythematosus. J Allergy Clin Immunol 137 (2016), 318–321.e5.
24. 24 Hori, S., Lineage stability and phenotypic plasticity of Foxp3(+) regulatory T cells. Immunol Rev 259 (2014), 159–172.
25. 25 Beriou, G., Costantino, C.M., Ashley, C.W., Yang, L., Kuchroo, V.K., Baecher-Allan, C., et al. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 113 (2009), 4240–4249.
26. 26 Guarda, G., Dostert, C., Staehli, F., Cabalzar, K., Castillo, R., Tardivel, A., et al. T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature 460 (2009), 269–273.